Smoking, plasma concentration, antipsychotic polypharmacy and adverse drug reaction burden in clozapine outpatients
Australian & New Zealand Journal of Psychiatry
Published online on January 17, 2026
Abstract
Australian & New Zealand Journal of Psychiatry, Volume 60, Issue 5, Page 493-505, May 2026.
Background:Clozapine is the most effective therapy for treatment-resistant schizophrenia, yet adverse drug reactions (ADRs) limit its use. The concurrent ADR burden in outpatients and its relation to psychotropic polypharmacy, tobacco smoking and measured ...
Background:Clozapine is the most effective therapy for treatment-resistant schizophrenia, yet adverse drug reactions (ADRs) limit its use. The concurrent ADR burden in outpatients and its relation to psychotropic polypharmacy, tobacco smoking and measured ...